Recce Pharmaceuticals Ltd Capital Reinvestment Ratio

Latest as of June 2026: 0.10x

Recce Pharmaceuticals Ltd capital reinvestment ratio. Recce Pharmaceuticals Ltd (RCE) has a Capital Reinvestment Ratio of 0.10x as of June 2026, meaning it reinvests 0% of its operating cash flow (AU$341.10K) in capital expenditures (AU$34.98K). Check Recce Pharmaceuticals Ltd (RCE) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.10x
Capex / Operating Cash Flow

Operating Cash Flow

AU$341.10K
AUD

Capital Expenditures

AU$34.98K
AUD

Data as of

Jun 2026
Most recent filing

Capital Reinvestment Ratio of Recce Pharmaceuticals Ltd (2014–2014)

Capital reinvestment ratio of Recce Pharmaceuticals Ltd from 2014 to 2014. This chart tracks Recce Pharmaceuticals Ltd's Capital Reinvestment Ratio across 1 annual periods. Also explore Recce Pharmaceuticals Ltd equity growth rate to track the company's year-over-year net asset growth rate.

Recce Pharmaceuticals Ltd Capital Reinvestment Ratio by Year (2014–2014)

Recce Pharmaceuticals Ltd capital reinvestment ratio by year from 2014 to 2014. For the full cash flow conversion analysis, see Recce Pharmaceuticals Ltd cash flow conversion.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2014 3.08x AU$11.43K AU$35.25K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow